Published in PLoS One on November 25, 2014
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Viral hepatitis C. Lancet (2003) 5.81
Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology (2002) 4.34
Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A (2001) 3.06
Alpha-1-acid glycoprotein. Biochim Biophys Acta (2000) 3.00
Hepatitis B virus infection. Lancet (2014) 2.78
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53
Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol (2006) 1.89
Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology (2004) 1.71
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res (2008) 1.48
Comparative human salivary and plasma proteomes. J Dent Res (2010) 1.41
The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res (2000) 1.41
Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics (2005) 1.33
Caeruioplasmin in liver disease. A diagnostic pitfall. Lancet (1962) 1.20
Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics (2005) 1.20
Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis (2005) 1.13
The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol (2009) 1.12
Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital (2011) 1.11
Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat (2008) 1.08
Hepatitis C virus proteins inhibit C3 complement production. J Virol (2011) 1.06
Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med (2013) 1.03
Saliva proteome research: current status and future outlook. Crit Rev Biotechnol (2012) 1.03
Quantitative analysis of the intra- and inter-subject variability of the whole salivary proteome. J Periodontal Res (2012) 1.02
Salivaomics. J Am Dent Assoc (2012) 1.01
Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics (2010) 1.01
Utility of salivary biomarkers for demonstrating acute myocardial infarction. J Dent Res (2014) 0.96
Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma. Oncotarget (2012) 0.95
One decade of salivary proteomics: current approaches and outstanding challenges. Clin Biochem (2012) 0.93
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One (2013) 0.91
New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients. J Proteome Res (2011) 0.90
Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepat Mon (2013) 0.89
Salivary proteomics in biomedical research. Clin Chim Acta (2012) 0.89
Hepcidin and the iron enigma in HCV infection. Virulence (2014) 0.88
Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis. Mol Biosyst (2013) 0.88
Knowledge and prevalence of viral hepatitis among beauticians. J Med Virol (2014) 0.87
Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease. PLoS One (2013) 0.86
Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia. Inflamm Res (2012) 0.85
Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma. BMC Res Notes (2010) 0.84
The intrinsic disorder status of the human hepatitis C virus proteome. Mol Biosyst (2014) 0.83
Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma. Hepatol Res (2012) 0.82
Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases. Acta Biochim Biophys Sin (Shanghai) (2013) 0.82
Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations. PLoS One (2013) 0.82
Serum iron markers in patients with chronic hepatitis C infection. Hepat Mon (2013) 0.81
An evaluation of saliva as an alternative to plasma for the detection of hepatitis C virus antibodies. Indian J Med Microbiol (2008) 0.80
[Ceruloplasmin level of patients with liver disease in China]. Zhonghua Nei Ke Za Zhi (2005) 0.79
Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery. Eur Arch Otorhinolaryngol (2012) 0.79
Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr (1979) 0.79